Work

P.0461 Population pharmacokinetic modeling and simulation to guide dose selection for TV-46000, a new long-acting formulation of risperidone for subcutaneous injection

Year: 2021

Type: article

Study design: Observational Study

Source: European Neuropsychopharmacology

DOI: 10.1016/j.euroneuro.2021.10.434

Authors: I. Perlstein, A. Merenlender Wagner, M. Lamson, O. Spiegelstein, P. Loupe, R. Gomeni, A. Elgart

Institution: Teva Pharmaceuticals (Israel)

Language: English

Topic: Smoking Behavior and Cessation

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4200225484

FWCI: 0.207

Cites: 1

Cited by: 1

Related to: 10